Safety Profile Overview
5-alpha reductase inhibitor for BPH and male pattern baldness. Controversial post-finasteride syndrome reports. Monitored for sexual dysfunction.
Generic Name
finasteride
Brand Names
Proscar, Propecia
Therapeutic Class
5-Alpha Reductase Inhibitor
Manufacturer
Merck
What Pharma Signal Tracks for Finasteride
- Adverse Events (FAERS) — All FDA Adverse Event Reporting System reports mentioning Finasteride, including serious outcomes, hospitalizations, and deaths.
- FDA Recalls — Class I, II, and III recalls, market withdrawals, and safety alerts related to Finasteride products.
- Label Changes — Boxed warning additions, new contraindications, dosing modifications, and safety-related labeling supplements.
- Risk Score — Composite risk score (0–100) combining adverse event rates, recall history, and label severity with explainable breakdown.
- Pharmacovigilance Signals — Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) analysis detecting disproportionate adverse reactions.
- Trend Analysis — Monthly time series with anomaly detection for emerging safety signals.
Data Disclaimer: Pharma Signal aggregates data from the FDA Adverse Event Reporting System (FAERS) and other public regulatory sources. FAERS reports do not establish causation. Report counts may reflect prescription volume rather than relative safety. Always consult healthcare professionals for medical decisions.
Get Finasteride Safety Data via API
One API call returns adverse events, risk scores, recalls, and pharmacovigilance signals for Finasteride.
curl "https://api.pharma-signal.com/drug/safety/finasteride" \ -H "X-API-Key: your_key" # Returns risk score, adverse event counts, # serious/death rates, recalls, and signals
Related Safety Intelligence
Pharma Signal provides comparative analysis across therapeutic classes. Compare Finasteride against other 5-Alpha Reductase Inhibitor drugs, or explore the full manufacturer portfolio for Merck.
- Head-to-head comparison — Compare up to 5 drugs side by side on all safety metrics.
- Therapeutic class benchmarking — See how Finasteride ranks within 5-Alpha Reductase Inhibitor on serious event rates.
- Company portfolio risk — View all drugs from Merck with aggregate risk exposure.
- AI analyst briefs — Get a natural-language safety assessment combining all data sources.